Render Target: STATIC
Render Timestamp: 2024-12-26T11:05:42.825Z
Commit: f2d32940205a64f990b886d724ccee2c9935daff
XML generation date: 2024-09-20 06:23:26.684
Product last modified at: 2024-12-17T19:02:23.847Z
Cell Signaling Technology Logo
1% for the planet logo
PDP - Template Name: Chemical Modulators
PDP - Template ID: *******c501c72

Thalidomide #83687

    Product Information

    Product Usage Information

    Thalidomide is supplied as a lyophilized powder. For a 15 mM stock, reconstitute 5 mg of powder in 1.29 mL of DMSO. Working concentrations and length of treatment can vary depending on the desired effect.

    Caution: Teratogenic. Pregnant women should avoid using this compound.

    Storage

    Store lyophilized at room temperature, desiccated. In lyophilized form, the chemical is stable for 24 months. Once in solution, store at -20ºC and use within 3 months to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

    Product Description

    Molecular Weight 258.2 g/mol
    Purity >98%
    Molecular Formula C13H10N2O4
    CAS 50-35-1
    Solubility Soluble in DMSO at 5 mg/mL.

    Background

    Thalidomide was briefly used as an antiemetic and sedative to treat “morning sickness,” anxiety, and insomnia before being removed from the market due to its association with neonatal mortality and severe birth defects. It reentered the clinical marketplace decades later as an antiangiogenic and anti-inflammatory agent effective against several forms of cancer, leprosy, and some inflammatory disorders (1,2). Thalidomide and its analogs, Lenalidomide and Pomalidomide, are immunomodulatory drugs that bind the CRL4 E3 ubiquitin ligase substrate receptor Cereblon (CRBN) to promote the ubiquitination and targeted degradation of several transcription factors. These compounds target several proteins, including C2H2 zinc finger transcription factors Ikaros, Aiolos, and ZFP91, as well as casein kinase 1α, to control a broad transcriptional network (3,4). Thalidomide can also downregulate the zinc finger transcription factor SALL4, which is implicated in some human malformation syndromes, including Duane-radial ray syndrome (Okihiro syndrome) and Acro-renal-ocular syndrome (5).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.